The microglial P2Y6 receptor as a therapeutic target for neurodegenerative diseases DOI Creative Commons
Jacob M. Dundee, Guy C. Brown

Translational Neurodegeneration, Journal Year: 2024, Volume and Issue: 13(1)

Published: Sept. 7, 2024

Language: Английский

Myeloid cell replacement is neuroprotective in chronic experimental autoimmune encephalomyelitis DOI
Marius Marc-Daniel Mader,

Alan Napole,

Danwei Wu

et al.

Nature Neuroscience, Journal Year: 2024, Volume and Issue: 27(5), P. 901 - 912

Published: March 21, 2024

Language: Английский

Citations

6

Senescent-like microglia limit remyelination through the senescence associated secretory phenotype DOI Creative Commons
Phillip S. Gross,

Violeta Durán Laforet,

Zeeba Manavi

et al.

bioRxiv (Cold Spring Harbor Laboratory), Journal Year: 2024, Volume and Issue: unknown

Published: May 26, 2024

ABSTRACT The capacity to regenerate myelin in the central nervous system (CNS) diminishes with age. This decline is particularly evident multiple sclerosis (MS), which has been suggested exhibit features of accelerated biological aging. Whether cellular senescence, a hallmark aging, contributes remyelination impairment remains unknown. Here, we show that senescent cells (SCs) accumulate within demyelinated lesions after injury, and their elimination enhances young mice but not aged mice. In mice, observed upregulation senescence-associated transcripts primarily microglia demyelination, followed by reduction during remyelination. However, factors persisted lesions, correlating inefficient We found SC enhanced was ineffective Proteomic analysis secretory phenotype (SASP) revealed elevated levels CCL11/Eotaxin-1 inhibit efficient oligodendrocyte maturation. These results suggest therapeutic targeting SASP components, such as CCL11, may improve aging MS.

Language: Английский

Citations

6

The Blood–Brain Barrier—A Key Player in Multiple Sclerosis Disease Mechanisms DOI Creative Commons
Thomas Gabriel Schreiner,

Constantin Romanescu,

Bogdan Ovidiu Popescu

et al.

Biomolecules, Journal Year: 2022, Volume and Issue: 12(4), P. 538 - 538

Published: April 2, 2022

Over the past decade, multiple sclerosis (MS), a chronic neuroinflammatory disease with severe personal and social consequences, has undergone steady increase in incidence prevalence rates worldwide. Despite ongoing research development of several novel therapies, MS pathology remains incompletely understood, prospect for curative treatment continues to be unpromising near future. A sustained effort, however, should contribute deeper understanding underlying mechanisms, which will undoubtedly yield improved results drug development. In recent years, blood-brain barrier (BBB) increasingly become focus many studies as it appears involved both onset progression. More specifically, neurovascular unit damage is believed critical process CNS immune cell penetration, subsequently favors CNS-specific response, leading classical pathological clinical hallmarks MS. The aim current narrative review merge relevant evidence on role BBB comprehensive succinct manner. Firstly, physiological structure functions component more complex are presented. Subsequently, authors specific alteration encountered different stages MS, focusing modifications cells neuroinflammation penetration cells. Finally, currently accepted theories neurodegeneration summarized.

Language: Английский

Citations

27

The Possible Role of Neural Cell Apoptosis in Multiple Sclerosis DOI Open Access
Peter G. E. Kennedy,

Woro George,

Xiaoli Yu

et al.

International Journal of Molecular Sciences, Journal Year: 2022, Volume and Issue: 23(14), P. 7584 - 7584

Published: July 8, 2022

The etiology of multiple sclerosis (MS), a demyelinating disease affecting the central nervous system (CNS), remains obscure. Although apoptosis oligodendrocytes and neurons has been observed in MS lesions, contribution this cell death process to pathogenesis controversial. It is usually considered that MS-associated demyelination axonal degeneration result from neuroinflammation an autoimmune targeting myelin proteins. However, experimental data indicate oligodendrocyte and/or neuronal may indeed precede development inflammation autoimmunity. These findings raise question as whether neural key event initiating driving pathological cascade, leading clinical functional deficits MS. Similarly, regarding damage, feature roles inflammation-independent autonomous processes need be further explored. While loss not necessarily mutually exclusive, particular attention should given role loss. If proven, could viewed primarily neurodegenerative accompanied by secondary neuroinflammatory process.

Language: Английский

Citations

25

Role of Vitronectin and Its Receptors in Neuronal Function and Neurodegenerative Diseases DOI Open Access

Yelizhati Ruzha,

Junjun Ni, Zhenzhen Quan

et al.

International Journal of Molecular Sciences, Journal Year: 2022, Volume and Issue: 23(20), P. 12387 - 12387

Published: Oct. 16, 2022

Vitronectin (VTN), a multifunctional glycoprotein with various physiological functions, exists in plasma and the extracellular matrix. It is known to be involved cell attachment, spreading migration through binding integrin receptor, mainly via RGD sequence. VTN also widely used maintenance expansion of pluripotent stem cells, but its effects go beyond that. Recent evidence shows more functions nervous system as it participates neural differentiation, neuronutrition neurogenesis, well regulating axon size, supporting guiding neurite extension. Furthermore, was proved play key role protecting brain can reduce permeability blood–brain barrier by interacting receptors vascular endothelial cells. Moreover, suggests that associated neurodegenerative diseases, such Alzheimer’s disease, function has not been fully understood. This review summarizes neurons describes diseases.

Language: Английский

Citations

23

Interactions Between Astrocytes and Oligodendroglia in Myelin Development and Related Brain Diseases DOI Creative Commons
Xuelian Hu,

Guangdan Yu,

Xiang Liao

et al.

Neuroscience Bulletin, Journal Year: 2022, Volume and Issue: 39(3), P. 541 - 552

Published: Nov. 12, 2022

Abstract Astrocytes (ASTs) and oligodendroglial lineage cells (OLGs) are major macroglial in the central nervous system. ASTs communicate with each other through connexin (Cx) Cx-based network structures, both of which allow for quick transport nutrients signals. Moreover, interact OLGs (Cx)-mediated networks to modulate various physiological processes brain. In this article, following a brief description infrastructural basis glial exocrine factors by may crosstalk, we focus on recapitulating how interactions between these two types myelination, AST-OLG involved protecting integrity blood-brain barrier (BBB) regulating synaptogenesis neural activity. Recent studies further suggest that associated myelin-related diseases, such as multiple sclerosis. A better understanding regulatory mechanisms underlying inspire development novel therapeutic strategies related brain diseases.

Language: Английский

Citations

20

Bromodomain and Extra-Terminal Proteins in Brain Physiology and Pathology: BET-ing on Epigenetic Regulation DOI Creative Commons
Noemi Martella, Daniele Pensabene,

Michela Varone

et al.

Biomedicines, Journal Year: 2023, Volume and Issue: 11(3), P. 750 - 750

Published: March 1, 2023

BET proteins function as histone code readers of acetylated lysins that determine the positive regulation in transcription genes involved cell cycle progression, differentiation, inflammation, and many other pathways. In recent years, thanks to development inhibitors, interest this protein family has risen for its relevance brain function. For example, experimental evidence shown modulation affects neuronal activity expression learning memory. addition, inhibition strongly suppresses molecular pathways related neuroinflammation. These observations suggest may play a critical role onset during diverse neurodegenerative neuropsychiatric disorders, such Alzheimer’s disease, fragile X syndrome, Rett syndrome. review article, we summarize most regarding involvement physiology pathology, well their pharmacological potential targets therapeutic purposes.

Language: Английский

Citations

13

Berberine promotes immunological outcomes and decreases neuroinflammation in the experimental model of multiple sclerosis through the expansion of Treg and Th2 cells DOI Creative Commons

Maryam Jadid Tavaf,

Azita Soltanmohammadi,

Simin Zargarani

et al.

Immunity Inflammation and Disease, Journal Year: 2023, Volume and Issue: 11(1)

Published: Jan. 1, 2023

Abstract Introduction Among the most frequent demyelinating autoimmune disorders of central nervous system (CNS) is multiple sclerosis. Experimental encephalomyelitis (EAE) used as an animal model Berberine alkaloid found in some medicinal plants with anti‐inflammatory effects. Methods C57BL/6 female mice were and divided into three groups: (1) The control group received PBS, (2) low‐dose treatment 10 mg/kg berberine, (3) high‐dose 30 berberine. Myelin Oligodendrocyte Glycoprotein complete Freund's adjuvant subcutaneously administered to induce EAE. Mice given intraperitoneal injections pertussis toxin on day immunization 2 days later. Histological studies showed low lymphocyte infiltration demyelination CNS treated groups. Results clinical scores berberine (T1: ± 0.13) (T2: 1.5 0.14) significantly ( p < .001) lower than (CTRL: 4.5 0.13). Treatment groups decreased pro‐inflammatory cytokines (IFN‐γ, TNF‐α, interleukin [IL]‐17) well increased cytokine expression (IL‐4, IL‐10, IL‐27, IL‐33, IL‐35, TGF‐β) .01) when compared CTRL group. reduced Th1 Th17 transcription factors Th2 Treg contrast Conclusion appears have a protective effect disease development alleviating status EAE, which be due cell expansion function cells addition berberine's properties.

Language: Английский

Citations

11

Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage: The Role of the Complement and Innate Immune System DOI Creative Commons
J. Javier Provencio,

Sonya Inkelas,

Mervyn D.I. Vergouwen

et al.

Translational Stroke Research, Journal Year: 2024, Volume and Issue: unknown

Published: Aug. 21, 2024

Specific inflammatory pathways are important in the development of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Understanding specific inflammation may be critical for finding new treatments. Evidence is accumulating that innate cells and proteins play a more role than adaptive system. In this work, we review evidence from clinical preclinical data regarding which immune system DCI with particular emphasis on bone-marrow-derived monocytes neutrophils brain parenchymal microglia. addition, will complement proteins, non-cellular part system, DCI.

Language: Английский

Citations

4

Senescent-like microglia limit remyelination through the senescence associated secretory phenotype DOI Creative Commons
Phillip S. Gross, Violeta Durán‐Laforet, Low Tone Ho

et al.

Nature Communications, Journal Year: 2025, Volume and Issue: 16(1)

Published: March 7, 2025

The capacity to regenerate myelin in the central nervous system diminishes with age. This decline is particularly evident multiple sclerosis (MS), a chronic demyelinating disease. Whether cellular senescence, hallmark of aging, contributes remyelination impairment remains unknown. Here, we show that senescent cells accumulate within demyelinated lesions after injury, and treatments senolytics enhances young middle-aged mice but not aged mice. In mice, observe upregulation senescence-associated transcripts, primarily microglia macrophages, demyelination, followed by reduction during remyelination. However, factors persist lesions, correlating inefficient Proteomic analysis secretory phenotype (SASP) reveals elevated levels CCL11/Eotaxin-1 which found inhibit oligodendrocyte maturation. These results suggest therapeutic targeting SASP components, such as CCL11, may improve aging MS. impact on authors treatment following demyelination young, these effects are mediated including CCL11.

Language: Английский

Citations

0